News
= LISA News
29.10.2020
RCPE erhält zwei Projekte von der U.S. Food and Drug Administration für Pharmatechnologie der nächsten Generation
29.10.2020
HOOKIPA Announces First Patient Dosed in Phase 1/2 Clinical Trial for HB-202/HB-201 Alternating Vector Therapy to Treat Human Papillomavirus16-Positive Cancers
27.10.2020
ONCOLOGICAL END-OF-LIFE CARE SHOWS: HIGH CARE INTENSITY, BUT LESS AND LATE PALLIATIVE CARE IN AUSTRIA
22.10.2020
Lexogens neuer LUTHOR Kit: Transkriptom-Sequenzierung von Einzelzellen und Proben mit extrem geringem Startmaterial
21.10.2020
Valneva Announces Positive Initial Results for Second Phase 2 Study of Lyme Disease Vaccine Candidate VLA15
20.10.2020
Rat für Forschung und Technologieentwicklung startet in seine fünfte Funktionsperiode
20.10.2020
HOOKIPA Appoints Prof. Jean-Charles Soria, Director General of the Gustave Roussy Cancer Center in Paris, to its Board of Directors